Makoto Ohno

15PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersRadiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 21, 2026
Role of antiseizure medication in postoperative late seizure and survival among patients with newly diagnosed glioblastoma: A multicenter retrospective study.

|Jul 23, 2026
Combination of re-irradiation and bevacizumab for recurrent adult histological pineoblastoma: a case report.

|Apr 03, 2026
Durable tumor control with stereotactic radiotherapy and doxorubucin-ifosfamide chemotherapy in primary intracranial sarcoma, DICER1-mutant: a case report.

Shohei Fujita, Makoto Ohno, Hirokazu Sugino

|Mar 05, 2025
Efficacy of radioactive hypoxia-targeting therapeutic agent 64Cu-ATSM on recurrent malignant glioma: a study protocol for a phase-III, investigator-sponsored, randomized controlled trial.

Yayoi Ando, Shunsuke Yanagisawa, Makoto Ohno

|Dec 11, 2024
Early progressive disease within 2 years in isocitrate dehydrogenase (IDH)-mutant astrocytoma may indicate radiation necrosis.

Yukie Ozeki, Mai Honda-Kitahara, Shunsuke Yanagisawa

|Sep 03, 2024
Cost of medical care for malignant brain tumors at hospitals in the Japan Clinical Oncology Group brain-tumor study group.

Kazuya Motomura, Keita Sasaki, Narushi Sugii

Pageof 3

Frequent Collaborators

10 joint publications

Yoshitaka Narita

3 joint publications

Masamichi Takahashi

2 joint publications

Yoshiki Arakawa

2 joint publications

Motoo Nagane